351 related articles for article (PubMed ID: 35163783)
1. Theranostic Interpolation of Genomic Instability in Breast Cancer.
Rasool R; Ullah I; Mubeen B; Alshehri S; Imam SS; Ghoneim MM; Alzarea SI; Al-Abbasi FA; Murtaza BN; Kazmi I; Nadeem MS
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163783
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Genomic Instability in Breast Cancer.
Duijf PHG; Nanayakkara D; Nones K; Srihari S; Kalimutho M; Khanna KK
Trends Mol Med; 2019 Jul; 25(7):595-611. PubMed ID: 31078431
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications.
Zito Marino F; Bianco R; Accardo M; Ronchi A; Cozzolino I; Morgillo F; Rossi G; Franco R
Int J Med Sci; 2019; 16(7):981-989. PubMed ID: 31341411
[TBL] [Abstract][Full Text] [Related]
4. Breast tumor copy number aberration phenotypes and genomic instability.
Fridlyand J; Snijders AM; Ylstra B; Li H; Olshen A; Segraves R; Dairkee S; Tokuyasu T; Ljung BM; Jain AN; McLennan J; Ziegler J; Chin K; Devries S; Feiler H; Gray JW; Waldman F; Pinkel D; Albertson DG
BMC Cancer; 2006 Apr; 6():96. PubMed ID: 16620391
[TBL] [Abstract][Full Text] [Related]
5. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability in breast cancer: pathogenesis and clinical implications.
Kwei KA; Kung Y; Salari K; Holcomb IN; Pollack JR
Mol Oncol; 2010 Jun; 4(3):255-66. PubMed ID: 20434415
[TBL] [Abstract][Full Text] [Related]
7. A 17-marker panel for global genomic instability in breast cancer.
Biermann J; Nemes S; Parris TZ; Engqvist H; Werner Rönnerman E; Kovács A; Karlsson P; Helou K
Genomics; 2020 Mar; 112(2):1151-1161. PubMed ID: 31260745
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
Sahin IH; Lowery MA; Stadler ZK; Salo-Mullen E; Iacobuzio-Donahue CA; Kelsen DP; O'Reilly EM
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):893-905. PubMed ID: 26881472
[TBL] [Abstract][Full Text] [Related]
9. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
[TBL] [Abstract][Full Text] [Related]
10. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
[TBL] [Abstract][Full Text] [Related]
11. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.
Chao HH; He X; Parker JS; Zhao W; Perou CM
PLoS One; 2012; 7(12):e51719. PubMed ID: 23284754
[TBL] [Abstract][Full Text] [Related]
12. BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
Holstege H; Horlings HM; Velds A; Langerød A; Børresen-Dale AL; van de Vijver MJ; Nederlof PM; Jonkers J
BMC Cancer; 2010 Nov; 10():654. PubMed ID: 21118481
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Predictive Biomarkers in Cancer.
Nair M; Sandhu SS; Sharma AK
Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
[TBL] [Abstract][Full Text] [Related]
14. Implications of genomic instability in the diagnosis and treatment of breast cancer.
Wiechec E
Expert Rev Mol Diagn; 2011 May; 11(4):445-53. PubMed ID: 21545260
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Genomic Instability in Breast Cancer.
Kalimutho M; Nones K; Srihari S; Duijf PHG; Waddell N; Khanna KK
Trends Pharmacol Sci; 2019 Mar; 40(3):198-211. PubMed ID: 30736983
[TBL] [Abstract][Full Text] [Related]
16. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
[TBL] [Abstract][Full Text] [Related]
17. Advances in breast cancer: pathways to personalized medicine.
Olopade OI; Grushko TA; Nanda R; Huo D
Clin Cancer Res; 2008 Dec; 14(24):7988-99. PubMed ID: 19088015
[TBL] [Abstract][Full Text] [Related]
18. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of breast cancers.
Curtis C
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
[TBL] [Abstract][Full Text] [Related]
20. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]